160 related articles for article (PubMed ID: 15172086)
41. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
42. One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial.
Fernandez H; Lucas C; Hédon B; Meyer JL; Mayenga JM; Roux C
Hum Reprod; 2004 Jun; 19(6):1465-71. PubMed ID: 15105403
[TBL] [Abstract][Full Text] [Related]
43. Effects of tibolone on the endometrium.
Völker W; Coelingh Bennink HJ; Helmond FA
Climacteric; 2001 Sep; 4(3):203-8. PubMed ID: 11588943
[TBL] [Abstract][Full Text] [Related]
44. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
Ivanov S; Kovachev E; Tsonev A; Abbud A
Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
[TBL] [Abstract][Full Text] [Related]
45. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
46. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches.
Nappi RE; Sances G; Sommacal A; Detaddei S; Facchinetti F; Cristina S; Polatti F; Nappi G
Menopause; 2006; 13(5):818-25. PubMed ID: 16894336
[TBL] [Abstract][Full Text] [Related]
47. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
48. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
Diaby V; Perreault S; Lachaine J
Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
[TBL] [Abstract][Full Text] [Related]
49. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
[TBL] [Abstract][Full Text] [Related]
50. [Tibolone therapy in postmenopausal women with a history of many risk factors].
Szántó F
Orv Hetil; 2003 Apr; 144(15):701-4. PubMed ID: 12774429
[TBL] [Abstract][Full Text] [Related]
51. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone.
Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C
Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912
[TBL] [Abstract][Full Text] [Related]
52. Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.
Klaassens AH; van Wijk FH; Hanifi-Moghaddam P; Sijmons B; Ewing PC; Ten Kate-Booij MJ; Kooi GS; Kloosterboer HJ; Blok LJ; Burger CW
Fertil Steril; 2006 Aug; 86(2):352-61. PubMed ID: 16828477
[TBL] [Abstract][Full Text] [Related]
53. Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
Jacobsen DE; Samson MM; Kezic S; Verhaar HJ
Maturitas; 2007 Sep; 58(1):7-18. PubMed ID: 17576043
[TBL] [Abstract][Full Text] [Related]
54. Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility.
Wang J; Zhou F; Dong M; Wu R; Qian Y
Fertil Steril; 2006 Apr; 85(4):1037-44. PubMed ID: 16580392
[TBL] [Abstract][Full Text] [Related]
55. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
[TBL] [Abstract][Full Text] [Related]
56. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M
Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
[TBL] [Abstract][Full Text] [Related]
57. [Treatment of hyperplasia endometrium with GNRH agonists].
Radowicki S; Skórzewska K
Ginekol Pol; 2003 Sep; 74(9):836-9. PubMed ID: 14674133
[TBL] [Abstract][Full Text] [Related]
58. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
[TBL] [Abstract][Full Text] [Related]
59. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
60. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy.
Nappi RE; Ferdeghini F; Sampaolo P; Vaccaro P; De Leonardis C; Albani F; Salonia A; Polatti F
Maturitas; 2006 Oct; 55(3):288-95. PubMed ID: 16730929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]